Centers for Disease Control and Prevention (2020, March). U.S. Opioid Prescribing Rate Maps. Retrieved from https://www.cdc.gov/drugoverdose/maps/rxrate-maps.html.
Agency for Healthcare Research and Quality (2019, September 18). New AHRQ Reports Highlight Seniors' Struggles with Opioids. Retrieved from https://www.ahrq.gov/news/newsroom/press-releases/seniors-struggles-with-opioids.html.
Texas Health and Human Services (2019, March). Opioids: An Epidemic Crisis. Retrieved from https://hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/QMP/opioids-epidemic-crisis.pdf (PDF).
U.S. Department of Health and Human Services (n.d.). Strategy to Combat Opioid Abuse, Misuse, and Overdose: A Framework Based on Five Point Strategy. Retrieved from https://www.hhs.gov/opioids/sites/default/files/2018-09/opioid-fivepoint-strategy-20180917-508compliant.pdf (PDF).
Weiss, A.J., Heslin, K.C., Barrett, M.L., Izar, R.I., & Bierman, A.S. (2018, September). Opioid-Related Inpatient Stays and Emergency Department Visits Among Patients Aged 65 and Older, 2010 and 2015. Retrieved from https://www.hcup-us.ahrq.gov/reports/statbriefs/sb244-Opioid-Inpatient-Stays-ED-Visits-Older-Adults.jsp.
Centers for Medicare & Medicaid Services (n.d.). Medicare Part D Opioid Prescribing Mapping Tool. Retrieved from https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/OpioidMap_Medicare_PartD.
American Psychiatric Association (2018, November). Opioid Use Disorder. Retrieved from https://www.psychiatry.org/patients-families/addiction/opioid-use-disorder/opioid-use-disorder.
Substance Abuse and Mental Health Services Administration (2017, September 15). Screening, Brief Intervention, and Referral to Treatment (SBIRT). Retrieved from https://www.samhsa.gov/sbirt.
Substance Abuse and Mental Health Services Administration (2020). Medications for Opioid Use Disorder. Retrieved from https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP20-02-01-006_508.pdf (PDF).
Substance Abuse and Mental Health Services Administration (2018). SAMSA Opioid Overdose Prevention Toolkit. Retrieved from https://store.samhsa.gov/product/Opioid-Overdose-Prevention-Toolkit/SMA18-4742?referer=from_search_result.
Substance Abuse and Mental Health Services Administration (2017, November). Rx Pain Medications, Know the Options, Get the Facts: Safe Storage of Prescription Medications. Retrieved from https://store.samhsa.gov/product/Rx-Pain-Medications-Know-the-Options-Get-the-Facts-/SMA17-5053-11?referer=from_search_result.
U.S. Food & Drug Administration (n.d.) Approved Risk Evaluation and Mitigation Strategies (REMS). Retrieved from https://www.accessdata.fda.gov/Scripts/Cder/Rems/index.cfm.
Rao, V.L., Micic, D., & Davis, A.M. (2019, November 4). Medical Management of Opioid-Induced Constipation. JAMA,
322(22), 2241–2242. DOI:10.1001/jama.2019.15852.
Krebs et al (2018, March 6). Effect of Opioid vs Non-opioid Medications on Pain-Related Function in Patients with Chronic Back Pain or Hip or Knee Osteoarthritis Pain. JAMA, 319(9), 872. DOI:10.1001/jama.2018.0899.
Stern, E.H. (2018). Evaluating the Relationship Between Physician Characteristics and Opioid Knowledge and Use of Opioid and Non-opioid Chronic Pain Management Strategies. PCOM Psychology Dissertations, 522. Retrieved from https://digitalcommons.pcom.edu/psychology_dissertations/522.
Skelly et al (2018, June 11). Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review. Comparative Effectiveness Review No. 209. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. 290-2015-00009-I.) AHRQ Publication No 18-EHC013-EF. DOI:10.23970/AHRQEPCCER209.
Trotter Davis, M., Bateman, B., & Avorn, J. (2017). Educational Outreach to Opioid Prescribers: The Case for Academic Detailing. Pain Physician, 20(2S), S147–S151.
Tompkins, D.A., Hobelmann, J.G., & Compton, P. (2017). Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma. Drug and Alcohol Dependence, 173 Suppl 1(Suppl 1), S11–S21. DOI:10.1016/j.drugalcdep.2016.12.002.
Berna, C., Kulich, R.J., & Rathmell, J.P. (2015, June). Tapering Long-term Opioid Therapy in Chronic Noncancer Pain: Evidence and Recommendations for Everyday Practice. Mayo Clinic Proceedings, 90(6), 828–842. DOI:10.1016/j.mayocp.2015.04.003.
Jamison, R.N., Sheehan, K.A., Scanlan, E., Matthews, M., & Ross, E.L. (2014). Beliefs and attitudes about opioid prescribing and chronic pain management: Survey of primary care providers. Journal of Opioid Management, 10(6), 375-382. DOI:10.5055/jom.2014.0234.
Rao et al (2020, March 1). Association of Formulary Exclusions and Restrictions for Opioid Alternatives with Opioid Prescribing Among Medicare Beneficiaries. JAMA Network Open,
3(3), e200274. DOI:10.1001/jamanetworkopen.2020.0274.
U.S. Department of Health and Human Services Working Group on Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics (2019, October). HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. Retrieved from https://www.hhs.gov/opioids/sites/default/files/2019-10/Dosage_Reduction_Discontinuation.pdf (PDF).
Centers for Disease Control and Prevention (n.d.). CDC Guideline for Prescribing Opioids for Chronic Pain. Retrieved from http://www.cdc.gov/drugoverdose/prescribing/guideline.html.
Institute for Healthcare Improvement (n.d.). Reducing Inappropriate Medication Use by Implementing Deprescribing Guidelines. Retrieved from http://www.ihi.org/resources/Pages/Publications/Evidence-Based-Medication-Deprescribing-Innovation-Case-Study.aspx.
Dowell, D., Haegerich, T.M., & Chou, R. (2016). CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 [Abstract]. MMWR Recomm Rep 2016;65(No. RR-1), 1-49. DOI:10.15585/mmwr.rr6501e1.
Mccarthy, M. (2015). Opioids should be last resort to treat chronic pain, says draft CDC guideline. BMJ, 351. DOI:10.1136/bmj.h6905.